menu
    • menu

    Company profile for Lumen Bioscience

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Lumen Bioscience discovers, develops and manufactures biologic drugs and vaccine candidates for several prevalent, worldwide diseases—many of which currently lack any effective treatments. The company’s unique drug development and manufacturing platform offers the potential to transform the biologics industry through increased speed, mass-market scale and exponentially lower costs than current approaches.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Lumen BioscienceUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    441 North 34th Street Suite 300 Seattle, WA 98103
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.lumen.bio/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lumen Bio's LMN-201: 100% Initial C. difficile Cure in RePreve Trial
    Lumen Bio's LMN-201: 100% Initial C. difficile Cure in RePreve Trial

    03 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lumen-biosciences-lmn-201-achieves-100-initial-c-difficile-clinical-cure-in-preliminary-cohort-of-repreve-trial-302419130.html

    PR NEWSWIRE
    03 Apr 2025
    Share Share
    Lumen gets $16M for C. diff drug; Flashpoint’s seed round
    Lumen gets $16M for C. diff drug; Flashpoint’s seed round

    17 Oct 2023

    // Jaimy Lee ENDPTS

    https://endpts.com/lumen-gets-16m-for-c-diff-drug-flashpoints-seed-round-amplifier-expands-series-a/

    Jaimy Lee ENDPTS
    17 Oct 2023
    Share Share
    Lumen Bioscience Awarded $8.8 million from U.S. Department of Defense
    Lumen Bioscience Awarded $8.8 million from U.S. Department of Defense

    11 May 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lumen-bioscience-awarded-8-8-million-from-us-department-of-defense-to-develop-fast-acting-intranasal-countermeasure-against-respiratory-viruses-301821803.html

    PR NEWSWIRE
    11 May 2023
    Share Share
    Lumen Bio Announces Clinical Advancement of LMN-201 for C. difficile Infection
    Lumen Bio Announces Clinical Advancement of LMN-201 for C. difficile Infection

    18 Apr 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/lumen-bioscience-announces-clinical-advancement-of-lmn-201-for-c-difficile-infection-301526716.html

    PRNEWSWIRE
    18 Apr 2022
    Share Share
    Lumen Bio Publishes Detailing of Spirulina-Based Platform on Large-Scale
    Lumen Bio Publishes Detailing of Spirulina-Based Platform on Large-Scale

    21 Mar 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/lumen-bioscience-announces-publication-in-nature-biotechnology-detailing-spirulina-based-platform-for-ultra-large-scale-production-of-therapeutic-proteins-301506415.html

    PRNEWSWIRE
    21 Mar 2022
    Share Share
    Lumen lands another DoD contract to treat Covid-related GI issues
    Lumen lands another DoD contract to treat Covid-related GI issues

    09 Oct 2021

    // J. Sullivan ENDPTS

    https://endpts.com/lumen-lands-another-dod-contract-to-treat-covid-related-gi-issues/

    J. Sullivan ENDPTS
    09 Oct 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search